65,437 trials
Focal Segmental Glomerulosclerosis
Primary: Slope of Estimated Glomerular Filtration Rate (eGFR) — -5.4; -5.7 milliliters/minute/1.73square meter/year — p=0.7491
Prostatic Neoplasms · Prostate Neoplasms · Prostate Cancer
Primary: Number of Participants With PSA Response — 0; 0 Participants
Flu
Primary: Overall Hemagglutinin Inhibition (HAI) H1N1 Titer Between FLUAD and FLUZONE HD at 1 Month Post-vaccination. — 213.4; 261.9; 70.5; 67.2 Titer
Bronchopulmonary Dysplasia · Chronic Lung Disease of Prematurity · Chronic Lung Disease
Primary: Intermittent Hypoxemia (IH) Events Per 8 Hours of Monitoring Time — 2.2; 1.2 IH events per 8 hours of monitoring time
Homozygous Familial Hypercholesterolemia
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Up to Week 216 — 93; 27 Number of participants
Violence, Sexual
Primary: Average Rating on Sexual Assertiveness at Baseline — 2.77 score on a scale
Chronic Migraine, Headache · Episodic Migraine
Primary: Mean Change in Pain Intensity Scores Measured by the Numeric Analog Scale (NRS) — 2.3; 1.1 score on a scale — p=0.013
Breast Cancer
Primary: Disease Control Rate (DCR) — 73.5; 78.0; 80.0 percentage of participants
Idiopathic Pulmonary Fibrosis
Primary: Part A - Number of Participants With Treatment-Emergent Adverse Events — 1 Participants
Warts
Primary: Complete Regression of Wart — 12; 10 Participants
Upper Gastrointestinal Bleeding · Peptic Ulcer Hemorrhage · Anticoagulant-induced Bleeding
Primary: ITT Analysis - Percent of Patients Reporting Medication Optimization — 30; 2; 29; 65 Participants — p=<0.001
Cystic Fibrosis
Primary: Time to an Exacerbation — 58; 51.5 Days — p=0.0715
Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
Primary: Overall Response Rate (ORR) by Independent Central Review (ICR) Assessment — 45.8; 68.3 percentage of participants — p=0.0017
Rheumatic Diseases
Primary: Percent of Appointments at Which Patient-Reported Outcomes Measurement Information System (PROMIS) Scores Are Documented in the Electronic Medical Record (EMR) Note by…
Pancreatic Insufficiency · Cystic Fibrosis
Primary: Coefficient of Fat Absorption — 80; 77 % fat absorption